chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Massive stroke; This spontaneous case was reported by a nurse and describes the occurrence of CEREBROVASCULAR ACCIDENT (Massive stroke) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Massive stroke) (seriousness criterion medically significant). At the time of the report, CEREBROVASCULAR ACCIDENT (Massive stroke) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment information was provided.  Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
felt very weak; could not focus on work and study; felt sore on my right face; migraine on the right side; have no feelings on my (entire) right face (including forehead,cheek, and jaw); hearing loss; could not get up the next day because of fever and sore arm(left); could not get up the next day because of fever and sore arm(left); This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW0173), via an unspecified route of administration, in left arm on 29Apr2021 11:00 (at the age of 37-years-old) as dose 1, single for COVID-19 immunization. Medical history included cosmetic allergy. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19 and since vaccination has not been tested for COVID-19. The patient did not receive any other vaccine within 2 weeks. After taking the vaccine, the patient could not get up the next day because of fever and sore arm on 30Apr2021. She felt very weak on an unspecified date and took ALEVE as treatment and got better. On 04May2021, the patient started to have no feelings on (entire) right face (including forehead, cheek, and jaw) and had migraine on the right side, hearing loss in the right ear. She was so terrified and went to do acupuncture after 2 days of the symptoms. Her hearing recovered after the first acupuncture. The patient did acupuncture twice and then went to do massages. Migraine recovered after several massage treatments and she started to have feelings on her right face gradually, but it was not the end, soon she felt sore on her right face, which made her very upset, and could not focus on work and study and until today (time of report), she was still bothered by it. She has to massage her face every day to alleviate the discomfort. The patient wanted to get some advice and help in order to recover fully from it. She did not take the second shot. The events resulted in doctor/ other healthcare professional visit. The outcome of the events hearing loss was recovered in May2021 and event migraine was recovered on an unspecified date. The outcome of all other events was not recovered.   Follow-up attempts are completed. No further information is expected.
Moderna Dose 1 at 11:00 am : Migraine with aura 40 minutes after injection - controlled with excedrin, resolved in the evening. 24hours after shot, increasing  pain at the location of she shot for 24 hours and resolved after a few days. No redness.  Dizziness spells started a few days after first dose and lasted for 2-3 weeks. Now resolved. Moderna Dose 2 at 11:00 am : Instant pain in the arm for a few hours. Chills and fever (38.9c) started 12 hours after the shot. 18 hours after the shot, strong  spinning sensation and  nausea, resolved after a few minutes by lying down on the cold floor. Pain under the armpit (no swelling) for 2/3 weeks. Persistent low grade headache at the back of the head  for 2/3 weeks.
Shortly after vaccination, patient's face became very red, she felt  lightheaded and had problems breathing. Symptoms resolved within minutes and blood pressure was found to be stable, thus no treatment was given. EMT arrived and agreed to no treatment.
within minutes of receiving  4 month vaccines (pediarix, Hib, Prevnar 13, rotarix) developed diffuse erythema of b/l legs, with some urticarial lesions. Fussy. Erythema faded within 10 minutes, but urticaria persisted, given 1.1 mg/kg benadryl X 1 with resolution of urtcaria within 30 minutes.   No other systemic s/s of reaction.
I have tinnitus in both ears, which I never had before. This was my 4th Moderna shot, or 2nd booster shot.
Pt recvd 1 dose of Engerix-B & the next day exp pain @ inject going down arm;
Moderna COVID-19 Vaccine EAU Red, itchy, swollen, raised patch over the injection site.  Extended approximately 2-3" around the injection
A rash on my left arm that was visibly red, warm to the touch, hurt when touched, and itched.
30apr2021 - my arm felt weak and felt like its broken and no muscle soreness . 19May2021 - My arm felt broken. JUn21st ruled out GMB. June 23 started taking Gabapentin - 600milligram a day. On 2 Jul and 12JUL Upper back and brain - MRI no lesions on the brain but 3 lesions on my mid back and neck. On Jul20th had spinal tap and diagnosed with MS . 2Aug2021 - 9Aug2021 - had 5 steroid drips, 1000milligrams of steroid each for 5 days . 21Oct 2021 - 1st treatment octrevous for MS. By Dr.  Doing ongoing treatment with nuerologists. with Octrevous with the doctors.
bad headache (pounding headache); body ache; chills; fever; sick; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: FA7485, expiration date: Oct2021) via an unspecified route of administration, administered in arm left on 27Jul2021 as DOSE 1, SINGLE for covid-19 immunisation (at the age of 54 year). Medical history included covid-19 from Dec2020 to Dec2020. Concomitant medications were not reported. The patient did not receive other products. The patient did not have any history. The patient stated, she got the vaccine on 27Jul2021 (tuesday morning). Stated that she had a fever on 27Jul2021 20:00 and cannot move because her headache was so bad (pounding headache), body ache and chills on 27Jul2021 22:00. Stated it was like having Covid again. Stated that she had covid back in Dec2020. Stated this was her first dose. Stated that her and her two daughters got it and she was the only one that got sick. The patient did not receive any treatment. The outcome of events was not recovered.  Follow-up attempts are completed. No further information was expected.
Severe headache, fatigue, body aches and fever of 100.3... not been able to get out of bed all day and at 9:00 PM 4/2/21, symptoms are just as bad as ever if not worse.
10 x 8 CM local reaction right posterior arm at site of Meningococcal vaccine itchy rash first noted 08/21/2005.  Treated with Allegra 180MG by mouth, Benadryl 50md every 4 hours.
12-year-old boy with post-COVID-vaccine-associated myocarditis who had presented with chest pain x1 day and recent fever (2 days prior to admission) after dose #2 of Pfizer vaccine. Of note, history of acute COVID infection on 12/29/2021, but negative COVID during admission. COVID-vaccine-induced myocarditis was suspected with low clinical suspicion for MIS-C given time course, no recent fever, and mildly elevated CRP, with no other concerning symptoms.   Troponins peaked at 1.66 and downtrended until 0.21 at time of discharge with recommendation for troponin recheck at 1 week while outpatient. Cardiology were consulted by the team, who recommended echo, which was unremarkable. EKG showed sinus rhythm. For chest pain, ibuprofen PRN was first-line, but patient denied chest pain and specific complaints for most of the hospital course. Patient was discharged in stable condition to home with appointment placed with cardiology and repeat troponin scheduled for 1 week post-discharge. Recommendation was to avoid strenuous activity and competitive sports for 3 months until clearance with treadmill.
More or less immediately after a flu vaccine (Fluzone, Sanofi Pasteur, Lot UH460AB) was injected in my right deltoid muscle I experienced pain at the injection site. Pain got increasingly worse during the day to the point that it became very difficult to hold a cup with my right rand, move a computer mouse, or move my right arm. Pain has now persisted for 3 days without improvement. I experience some but not complete resolution after taking ibuprofen 200-400 mg PO and/or acetaminophen 500 mg PO. I feel very compromised in my daily activities despite taking pain medication.
Pt reported a lump in her throat 10 min after the injections. Pt thought she needed a drink of water. Pt reported to feeling fine and returned to work. Pt then reported to the ER with dizziness and lump in her throat at 2:18pm. Pt was admitted to hospital for observation overnight.
The site of injection was red and tender to the touch. Signs of inflammation at site. When asked if any trouble breathing, patient mentions "slight issues with breathing."
Patient came to the pharmacy to receive her Prevnar 13 vaccination.  She had previously received Pneumovax 23 a few years prior and it was recommended to her by her physician to receive the Prevnar 13.  She had indicated that she had no known drug/latex allergies.  The patient reported that 3 to 4 days after the injection of Prevnar 13, the site of injection began to turn purple in color.  Subsequent to that, a redness also appeared on or around the purple coloration and has grown incrementally since it appeared.  She has reported no extraordinary pain or swelling at the site of injection. She currently does not experience any pain or swelling at the site.  She did report feeling fatigued for at least 4 days post injection and is still slightly fatigued.  She has not applied any ice or used any anti-inflammatories since the injection.  Upon being notified of the event, the pharmacist interviewed the patient over the phone to record the pertinent information as well as to encourage the patient to contact her physician with regard to this event.
Localized rednes and irritation at site of injection - treatment, monitoring and OTC benadryl and tylenol for inflammation.
This spontaneous report as received from a healthcare worker (medical assistant) refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 12-FEB-2015, the patient was vaccinated with the second dose of PROQUAD injection 0.5 ml administered subcutaneously (lot # K008158 with expiry date: 12-NOV-2015; strength unspecified) after it was improperly stored. No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: difficulty walking-Medium, Additional Details: patient had to be administered to hospital 2 weeks after shingrix, dr's are ruling out everything, ct, x-ray, stroke, doesn't have a definitive diagnosis, possible GBS.  wife called to let us know. dr's haven't determined the exact cause. patient unaware of any problems or issues and unaware of any GBS at the time of shingrix. patient had previous vaccines without any problems.
Information has been received from a physician concerning a female with a history of asthma, attention deficit/hyperactivity disorder, chronic upper respiratory infections, gastroesophageal reflux disease and allergic reaction to Augmentin, who on 28-AUG-2007 was vaccinated with her first dose of Gardasil vaccine IM (lot# 656371/0181U) and Zithromax for an STD. Concomitant therapy included Vyvanse 30mg, Septra as needed, Advair, Proventil Inhaler, Aciphex 20mg and Clarinex. On 28-AUG-2007, the patient experienced vomiting within six hours of receiving Gardasil vaccine. The patient called the office reporting she had nausea and a headache. The patient took Advil and Tylenol. On 05-SEP-2007, the patient was seen in the office with continuing vomiting and nausea and also diarrhea and a fever to 102F. The patient was treated with Phenergan. On 12-OCT-2007, the patient was vaccinated with her second dose of Gardasil vaccine (lot 657868/0523U) and within 24 hours the patient experienced vomiting. On 16-OCT-2007, the patient was seen for a blood test and sedrate was high. The patient is recovering from vomiting, nausea, diarrhea, fever and headache. Therapy was discontinued. Additional information has been requested.
Information has been received from a registered pharmacist and a registered nurse concerning a patient who on Oct 11, 2002, was vaccinated by the registered nurse with a dose of pneumococcal vaccine 23 polyvalent, intramuscularly (lot #640981/1050L expiration date May 16, 2003), intramuscularly in the deltoid. The registered pharmacist reported that he heard from a physician's office that three members of the office staff received pneumococcal vaccine 23 polyvalent and experienced swelling from the site of the injection down to almost the elbows. The registered nurse reported that three employees were vaccinated with pneumococcal vaccine 23 polyvalent on Oct 11, 2002. All three patients experienced soreness in a few hours. The swelling appeared that night. The area was warn and inflamed. Two of the patients were treated with ice. The reactions seemed to resolved in 48 hours. Unspecified medical attention was sought. The records of testing priori to release of this lot have been checked by compliance and found to be satisfactory. The lot complies with the standards of the evaluation and research and was released. Additional information has been requested.
shortness of breath; difficulties after a five-minute walk where I'm having difficulties; have a small cough which I started after the first shot and two months past the second shot and it just seems to be getting a little worse; This is a spontaneous report from a contactable consumer (Patient). A 54-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration, administered in right arm on 14Mar2021 (at the age of 54 years old) as a single dose for COVID-19 immunisation. The patient's medical history was none reported. The patient had penicillin allergies. The patient's concomitant medications were none reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID prior vaccination. The patient was not tested COVID post vaccination. The patient took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6200) via an unspecified route of administration, administered in left arm on an unspecified date as a single dose for COVID-19 immunization and experienced small cough. On 14Mar2021 at 20:30 the patient experienced shortness of breath, difficulties after a five-minute walk where I'm having difficulties and have a small cough which I started after the first shot and two months past the second shot, and it just seems to be getting a little worse. The patient reported that patient had problems with breathing after only 5 or 10 minutes of exercise which patient did not have before and took the first shot the patient also had a small cough which patient started after the first shot, and it seems to have not gone away. The patient did not receive any treatment for the events. The reporter reported the events as non-serious. The patient visited physician office due to events. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
This is a spontaneous report from a contactable lawyer. A 65 year old male patient received PREVENAR 13 in late Sep2016 at single dose in left shoulder for pneumonia immunization, and influenza vaccine (FLU VACCINE VII) in right shoulder. Medical history and concomitant medication were not reported. In Oct2016, two weeks after getting the shot, the patient experienced left shoulder at the injection site seriously infected. The patient was seen by a facility that is not primary care physicians, but at an urgent care facility. He saw several urgent care doctors at a facility and was prescribed the antibiotics that didn't work. Patient went to a dermatologist about 10 days ago and had a biopsy done on 31Oct2016 waiting to get results from a lab as to what antibiotics might best be used to fight this infection. The patient has tried numerous antibiotics that did not work. Stated the names of the antibiotics might not be the precise name, but the name as the patient gave. These were KEFLEX, BACTRIM, Amoxicillin, and two other shots which he doesn't know whether they were antibiotic shots or not. Caller has no information on any of these products. At the time of the report the outcome was not recovered but mildly worsened.
My daughter got HOV vaccine and has been sick since her injection-2 huge outbreaks of cold sores--missed school
Information has been received from a nurse referring to two unspecified patients of unknown age and gender. The patients' concurrent condition, medical history and concomitant therapy were not reported. On 30-AUG-2017, the patients were vaccinated with doses of improperly stored PROQUAD (dose and frequency were unknown; lot # N008826 with expiration date 12-SEP-2018) subcutaneously for prophylaxis, which were exposed to temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit for 114 hours. There were no previous temperature excursions. DILUENT was stored properly. No data logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000580.
The claim did not go through in the computer for Flublok for an 11yo boy then I forgot that flublok is only for 18yo and older. Called the Sanofi and ask if there is any adverse reaction of giving the flublok to an 11yo and they said they did a study 6-17yo and the vaccine was well tolerated and same side effect profile and same efficacy as the regular vaccines that were approved for kids <18yo. Called the mom and let her know what happened and let her know what the manufacturer said as well. The mom was fine. Mom called back 30 minutes later claiming the son is having stomach pains and going to the bathroom but no nausea vomiting or any other symptoms. Spoke to mom and recommended mom to bring the son to the doctor and check back with the mom tomorrow or the next day. put in scrt
burning in her arm; right arm and right leg became numb; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning in her arm) and HYPOAESTHESIA (right arm and right leg became numb) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced BURNING SENSATION (burning in her arm) and HYPOAESTHESIA (right arm and right leg became numb). At the time of the report, BURNING SENSATION (burning in her arm) and HYPOAESTHESIA (right arm and right leg became numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant information  provided. Treatment included Tylenol and documenting all the times that she took it.
a red, raised welt-like rash appeared below the area where shot was administered; area was warm to touch; rash remained until 15JUL94;
No adverse effects; two patients were administered an expired dose of properly stored PNEUMOV AX 23 (lot R012713 and expiration 03-AUG-2019); This spontaneous report has been received from a nurse referring to a 75-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant medications were not provided.         On 06-AUG-2019, the patient was vaccinated with an expired dose of properly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) (lot # R012713, expiration date was reported as 03-AUG-2019; dose and route were not reported) in the left deltoid for prophylaxis. No adverse effects reported. Post expiry memo vaccines and biologics administered did support the administration of expired vaccine. No additional information provided. The outcome of the event was unknown.     The causality between the event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.   This is one of 2 reports received from the same reporter.
The pt was discovered collapsed, cyanotic, and not breathing approximately 8 hours post vax. Diagnosed with inducible polymorphic ventricular tachycardia
Rash on trunk area - not pustular - rash began 1 wk after vaccine. 1 wk prior to rash -> cold sxs. Area with pale purplish red urticaria on (R) thigh (injection site) approx 3 cm diameter.
Fully vaccinated, not boosted.  Asymptomatic COVID breakthrough infection.  Admit in labor, delivered full term (40w3d) baby. Apgars 8/9   7#13 oz
MMR given 1-3-02 Fever and rash began to 1-12-02 pt. seen 1-14-02, low grade temperature unresolved. O M still noted. Patient was on amoxicillin. Rash appeared to be measles and not drug eruptions.
65 year old and over flu vaccine was given to a 48 year old male patient, Patient was made aware of the adverse event and informed about the vaccine that was given along with symptoms to look out for patient was advised if he was having any shortness of breath or vaccine site were to become swollen and our office happened to be closed to report to the ER, Patient stated he was feeling fine and had no symptoms.
Constant extreme pain in shoulders and arms as if flesh being torn off the bone.  Moved to hips and knees. Painful to move. Unable to sleep for weeks.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 61-year-old female patient who received SHINGRIX (batch number 3NY5G, expiry date 7th March 2021) for prophylaxis. On 27th October 2018, the patient received the 1st dose of SHINGRIX. On 27th October 2018, 6 hrs after receiving SHINGRIX, the patient experienced fever, chills, headache and muscle pain. On an unknown date, the outcome of the fever, chills, headache and muscle pain were recovered/resolved. It was unknown if the reporter considered the fever, chills, headache and muscle pain to be related to SHINGRIX. Additional information received as follows: The patient received SHINGRIX on the left deltoid. The reporter stated that the patient experienced fever, chills, headache, and muscle aches 6 to 8 hours after receiving her first dose of SHINGRIX. These symptoms subsided 24 hours later. The reporter consented to follow up.
Vaccine was administered on 3-14-21 but Covid-19 Vaccination Record Card was back dated to 3-13-21. It is believed that vial had been open for more than 6 hours at time of administration.
5mm bruise at injection site, one inch below injection site one cm lump, red increasing warmth with blister and pain.
Narrative: 73 y/o old male presented to ER on 01/27/22 with N/V, diarrhea, fever, and weakness. Recently d/c on antibiotics for cellulitis. COVID positive. Treated with remdesivir and dexamethasone. Hospital course complicated with C. Diff infection and hypersmolar hyponatremia. Discharged 02/5/22. PMH includes HTN, morbid obesity, hyperlipidemia, BPH, atrial flutter, overactive bladder, osteoarthritis, and skin basal cell carcinoma.